Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Melatonin applied to the scalp helps increase hair density in people with early hair loss.

Melatonin applied to the scalp helps treat early-stage hair loss in men and women.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

A new gene, JMJD1C, may affect testosterone levels in men.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Lower DHT and higher testosterone levels increase brain activation but don't change behavior in heavy drinkers.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

PSA can help diagnose high androgen levels in women.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.